Hims & Hers Health, Inc. (NYSE: HIMS) reported Q2 EPS of ($0.10), $0.02 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $113.6 million versus the consensus estimate of $103.89 million.

For earnings history and earnings-related data on Hims & Hers Health, Inc. (HIMS) click here.